83 related articles for article (PubMed ID: 1869974)
1. Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas.
Dehdashti F; McGuire AH; Van Brocklin HF; Siegel BA; Andriole DP; Griffeth LK; Pomper MG; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1991 Aug; 32(8):1532-7. PubMed ID: 1869974
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of a [18F]fluorine labeled progestin (21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone) in humans: a clue for future investigations.
Verhagen A; Studeny M; Luurtsema G; Visser GM; De Goeij CC; Sluyser M; Nieweg OE; Van der Ploeg E; Go KG; Vaalburg W
Nucl Med Biol; 1994 Oct; 21(7):941-52. PubMed ID: 9234348
[TBL] [Abstract][Full Text] [Related]
3. A fluorine-18 labeled progestin as an imaging agent for progestin receptor positive tumors with positron emission tomography.
Verhagen A; Elsinga PH; de Groot TJ; Paans AM; de Goeij CJ; Sluyser M; Vaalburg W
Cancer Res; 1991 Apr; 51(7):1930-3. PubMed ID: 2004378
[TBL] [Abstract][Full Text] [Related]
4. 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone: synthesis and target tissue selective uptake of a progestin receptor based radiotracer for positron emission tomography.
Pomper MG; Katzenellenbogen JA; Welch MJ; Brodack JW; Mathias CJ
J Med Chem; 1988 Jul; 31(7):1360-3. PubMed ID: 3260285
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of a positron emitting progestin ([18F]fluoro-16 alpha-methyl-19-norprogesterone) for imaging progesterone receptor positive tumours with positron emission tomography.
Verhagen A; Luurtsema G; Pesser JW; de Groot TJ; Wouda S; Oosterhuis JW; Vaalburg W
Cancer Lett; 1991 Aug; 59(2):125-32. PubMed ID: 1884369
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of breast cancer with fluorine-18 radiolabeled estrogens and progestins.
Jonson SD; Welch MJ
Q J Nucl Med; 1998 Mar; 42(1):8-17. PubMed ID: 9646640
[TBL] [Abstract][Full Text] [Related]
7. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
8. Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.
Lee JH; Zhou HB; Dence CS; Carlson KE; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 2010 Jun; 21(6):1096-104. PubMed ID: 20496889
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-labeled progestin ketals: synthesis and target tissue uptake selectivity of potential imaging agents for receptor-positive breast tumors.
Kochanny MJ; VanBrocklin HF; Kym PR; Carlson KE; O'Neil JP; Bonasera TA; Welch MJ; Katzenellenbogen JA
J Med Chem; 1993 Apr; 36(9):1120-7. PubMed ID: 8487253
[TBL] [Abstract][Full Text] [Related]
10. Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.
McGuire AH; Dehdashti F; Siegel BA; Lyss AP; Brodack JW; Mathias CJ; Mintun MA; Katzenellenbogen JA; Welch MJ
J Nucl Med; 1991 Aug; 32(8):1526-31. PubMed ID: 1869973
[TBL] [Abstract][Full Text] [Related]
11. Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity.
Buckman BO; Bonasera TA; Kirschbaum KS; Welch MJ; Katzenellenbogen JA
J Med Chem; 1995 Jan; 38(2):328-37. PubMed ID: 7830275
[TBL] [Abstract][Full Text] [Related]
12. An efficient route for the preparation of a 21-fluoro progestin-16 alpha,17 alpha-dioxolane, a high-affinity ligand for PET imaging of the progesterone receptor.
Vijaykumar D; Mao W; Kirschbaum KS; Katzenellenbogen JA
J Org Chem; 2002 Jul; 67(14):4904-10. PubMed ID: 12098304
[TBL] [Abstract][Full Text] [Related]
13. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and organ distribution of [18F]fluoro-Org 6141 in the rat: a potential glucocorticoid receptor ligand for positron emission tomography.
Visser GM; Krugers HJ; Luurtsema G; van Waarde A; Elsinga PH; deKloet ER; Groen MB; Bohus B; Go KG; Paans AM
Nucl Med Biol; 1995 Oct; 22(7):915-20. PubMed ID: 8547889
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer: PET imaging of estrogen receptors.
Mintun MA; Welch MJ; Siegel BA; Mathias CJ; Brodack JW; McGuire AH; Katzenellenbogen JA
Radiology; 1988 Oct; 169(1):45-8. PubMed ID: 3262228
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Zhou D; Sharp TL; Fettig NM; Lee H; Lewis JS; Katzenellenbogen JA; Welch MJ
Nucl Med Biol; 2008 Aug; 35(6):655-63. PubMed ID: 18678350
[TBL] [Abstract][Full Text] [Related]
17. Designing steroid receptor-based radiotracers to image breast and prostate tumors.
Katzenellenbogen JA
J Nucl Med; 1995 Jun; 36(6 Suppl):8S-13S. PubMed ID: 7769466
[TBL] [Abstract][Full Text] [Related]
18. Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose.
Wahl RL; Cody R; Hutchins G; Mudgett E
N Engl J Med; 1991 Jan; 324(3):200. PubMed ID: 1984203
[No Abstract] [Full Text] [Related]
19. Synthesis of [18F]fluoro-labeled progestins for PET.
de Groot TJ; Verhagen A; Elsinga PH; Vaalburg W
Int J Rad Appl Instrum A; 1991; 42(5):471-4. PubMed ID: 1646193
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of [18F]fluoroalanine and [18F]fluorotamoxifen for imaging breast tumors.
Yang D; Kuang LR; Cherif A; Tansey W; Li C; Lin WJ; Liu CW; Kim EE; Wallace S
J Drug Target; 1993; 1(3):259-67. PubMed ID: 8069568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
